Pound et al developed an algorithm for predicting the likelihood of metastatic disease in a man who has undergone a radical prostatectomy for prostate cancer. This can help identify a patient who may benefit from more aggressive management. The authors are from the Johns Hopkins University and Merck Research Laboratories.
Parameters:
(1) Gleason score in the surgical specimen
(2) time to PSA recurrence in months
(3) PSA doubling time in months
Gleason Score |
Time to PSA Recurrence |
PSA Doubling Time |
Group |
5 to 7 |
> 24 months |
> 10 months |
A |
5 to 7 |
> 24 months |
<= 10 months |
B |
5 to 7 |
<= 24 months |
> 10 months |
C |
5 to 7 |
<= 24 months |
<= 10 months |
D |
8 to 10 |
> 24 months |
NA |
E |
8 to 10 |
<= 24 months |
NA |
F |
where:
• Patients with a Gleason score of <= 4 were not included in the algorithm.
Group |
Percent Metastasis Free at 5 Years |
Percent Metastasis Free at 7 Years |
A |
86% |
82% |
B |
69% |
60% |
C |
76% |
59% |
D |
35% |
15% |
E |
60% |
47% |
F |
31% |
21% |
Specialty: Hematology Oncology, Surgery, general, Urology